Experimental infection with Haemophilus ducreyi in persons who are infected with HIV does not cause local or augment systemic viral replication

Journal of Infectious Diseases

Volumn 195, Issue 10, 2007, Pages 1443-1451

  Janowicz, Diane M ^a,f   Tenner Racz, Klara ^d   Racz, Paul ^d   Humphreys, Tricia L ^a,e   Schnizlein Bick, Carol ^a   Fortney, Kate R ^a   Zwickl, Beth ^a   Katz, Barry P ^a   Campbell, James J ^b   Ho, David D ^c   Spinola, Stanley M ^a  

^a INDIANA UNIVERSITY   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c ROCKEFELLER UNIVERSITY   (United States)

^d BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

^e GRINNELL COLLEGE   (United States)

^f 435 Emerson Hall ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ARTICLE; BIOPSY; CD4 CD8 RATIO; CD4 LYMPHOCYTE COUNT; CELL INFILTRATION; CELL PROLIFERATION; CONTROLLED STUDY; EXPERIMENTAL INFECTION; FEMALE; GENITAL ULCER; HAEMOPHILUS DUCREYI; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN SITU HYBRIDIZATION; LEUKOCYTE; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; PAPULE; PRIORITY JOURNAL; PUSTULE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; CHANCROID; FEMALE; HAEMOPHILUS DUCREYI; HIV INFECTIONS; HUMANS; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MALE; RNA, VIRAL; VIRAL LOAD; VIRUS REPLICATION;

EID: 34248207207     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/513877     Document Type: Article

References (48)

1. Steen R. Eradicating chancroid. Bull World Health Organ 2001; 79: 818-26.
2. Hayes RJ, Schulz KF, Plummer FA. The cofactor effect of genital ulcers on the per-exposure risk of HIV transmission in sub-Saharan Africa. J Trop Med Hyg 1995; 98:1-8.
3. Cohen MS. Thomas Parran Award Lecture: transmission and prevention of transmission of HIV-1. Sex Transm Dis 2006; 33:338-41.
4. Orroth KK, White RG, Korenromp EL, et al. Empirical observations underestimate the proportion of human immunodeficiency virus infections attributable to sexually transmitted diseases in the Mwanza and Rakai sexually transmitted disease treatment trials: simulation results. Sex Transm Dis 2006; 33:536-44.
5. Robinson NJ, Mulder DW, Auvert B, Hayes RJ. Proportion of HIV infections attributable to other sexually transmitted diseases in a rural Ugandan population: simulation model estimates. Int J Epidemiol 1997; 26:180-9.
6. Dyer JR, Eron JJ, Hoffman IF, et al. Association of CD4 cell depletion and elevated blood and seminal plasma human immunodeficiency virus type 1 (HIV-1) RNA concentrations with genital ulcer disease in HIV-1-infected men in Malawi. J Infect Dis 1998; 177:224-7.
7. Al-Tawfiq JA, Thornton AC, Katz BP, et al. Standardization of the experimental model of Haemophilus ducreyi infection in human subjects. J Infect Dis 1998; 178:1684-7.
8. Spinola SM, Bauer ME, Munson RS Jr. Immunopathogenesis of Haemophilus ducreyi infection (chancroid). Infect Immun 2002; 70:1667-76.
9. Spinola SM, Orazi A, Arno JN, et al. Haemophilus ducreyi elicits a cutaneous infiltrate of CD4 cells during experimental human infection. J Infect Dis 1996; 173:394-402.
10. King R, Gough A, Nasio J, Ndinya-Achola F, Plummer F, Wilkins J. An immunohistochemical analysis of naturally occurring chancroid. J Infect Dis 1996; 174:427-30.
11. Magro CM, Crowson AN, Alfa M, et al. A morphological study of penile chancroid lesions in human immunodeficiency virus (HIV)-positive and -negative African men with a hypothesis concerning the role of chancroid in HIV transmission. Hum Pathol 1996; 27:1066-70.
12. Palmer KL, Schnizlein-Bick CT, Orazi A, et al. The immune response to Haemophilus ducreyi resembles a delayed-type hypersensitivity reaction throughout experimental infection of human subjects. J Infect Dis 1998; 178:1688-97.
13. Bauer ME, Goheen MP, Townsend CA, Spinola SM. Haemophilus ducreyi associates with phagocytes, collagen, and fibrin and remains extracellular throughout infection of human volunteers. Infect Immun 2001; 69:2549-57.
14. Bauer ME, Spinola SM. Localization of Haemophilus ducreyi at the pustular stage of disease in the human model of infection. Infect Immun 2000; 68:2309-14.
15. Bauer ME, Townsend CA, Ronald AR, Spinola SM. Localization of Haemophilus ducreyi in naturally acquired chancroidal ulcers. Microbes Infect 2006; 8:2465-8.
16. Abeck D, Eckert F, Korting HC. Atypical presentation of co-existent Haemophilus ducreyi and Treponema pallidum infection in an HIV-positive male. Acta Derm Venereol 1992; 72:37-8.
17. Quale J, Teplitz E, Augenbraun M. Atypical presentation of chancroid in a patient infected with the human immunodeficiency virus. Am J Med 1990; 88:43N-44N.
18. Malonza IM, Tyndall MW, Ndinya-Achola JO, et al. A randomized, double-blind, placebo-controlled trial of single-dose ciprofloxacin versus erythromycin for the treatment of chancroid in Nairobi, Kenya. J Infect Dis 1999; 180:1886-93.
19. Ballard RC, Ye H, Matta A, Dangor Y, Radebe F. Treatment of chancroid with azithromycin. Int J STD AIDS 1996; 7(Suppl 1):9-12.
20. Bogaerts J, Kestens L, Tello WM, et al. Failure of treatment for chancroid in Rwanda is not related to human immunodeficiency virus infection: in vitro resistance of Haemophilus ducreyi to trimethoprim- sulfamethoxazole. Clin Infect Dis 1995; 20:924-30.
21. King R, Choudhri SH, Nasio J, et al. Clinical and in situ cellular responses to Haemophilus ducreyi in the presence or absence of HIV infection. Int J STD AIDS 1998; 9:531-6.
22. Janowicz DM, Fortney KR, Katz BP, et al. Expression of the LspA1 and LspA2 proteins by Haemophilus ducreyi is required for virulence in human volunteers. Infect Immun 2004; 72:4528-33.
23. Janowicz D, Leduc I, Fortney KR, Katz BP, Elkins C, Spinola SM. A DltA mutant of Haemophilus ducreyi is partially attenuated in its ability to cause pustules in human volunteers. Infect Immun 2006; 74:1394-7.
24. Janowicz D, Luke NR, Fortney KR, Katz BP, Campagnari AA, Spinola SM. Expression of OmpP2A and OmpP2B is not required for pustule formation by Haemophilus ducreyi in human volunteers. Microb Pathog 2006; 40:110-5.
25. Fulcher RA, Cole LE, Janowicz DM, et al. Expression of Haemophilus ducreyi collagen binding outer membrane protein NcaA is required for virulence in swine and human challenge models of chancroid. Infect Immun 2006; 74:2651-8.
26. Humphreys TL, Baldridge LA, Billings SD, Campbell JJ, Spinola SM. Trafficking pathways and characterization of CD4 and CD8 cells recruited to the skin of humans experimentally infected with Haemophilus ducreyi. Infect Immun 2005; 73:3896-902.
27. Soler D, Humphreys TL, Spinola SM, Campbell JJ. CCR4 versus CCR10 in human cutaneous Th lymphocyte trafficking. Blood 2003; 101: 1677-83.
28. Fortney KR, Young RS, Bauer ME, et al. Expression of peptidoglycan- associated lipoprotein is required for virulence in the human model of Haemophilus ducreyi infection. Infect Immun 2000; 68:6441-8.
29. Young RS, Filiatrault MJ, Fortney KR, et al. Haemophilus ducreyi lipooligosaccharide mutant defective in expression of B1,4-glucosyltransferase is virulent in humans. Infect Immun 2001; 69:4180-4.
30. Tenner-Racz K, Stellbrink H-J, van Lunzen J, et al. The unenlarged lymph nodes of HIV-1-infected, asymptomatic patients with high CD4 T cell counts are sites for virus replication and CD4 T cell proliferation: the impact of highly active antiretroviral therapy. J Exp Med 1998; 187:949-59.
31. de Saint-Vis B, Fugier-Vivier I, Massacrier C, et al. The cytokine profile expressed by human dendritic cells is dependent on cell subtype and mode of activation. J Immunol 1998; 160:1666-76.
32. Zhang L, Ramratham B, Tenner-Racz K, et al. Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy. N Engl J Med 1999; 340:1605-13.
33. Humphreys TL, Schnizlein-Bick CT, Katz BP, et al. Evolution of the cutaneous immune response to experimental Haemophilus ducreyi infection and its relevance to HIV-1 acquisition. J Immunol 2002; 169: 6316-23.
34. Spinola SM, Bong CTH, Faber AL, et al. Differences in host susceptibility to disease progression in the human challenge model of Haemophilus ducreyi infection. Infect Immun 2003; 71:6658-63.
35. Hellerstein MK, Hoh RA, Hanley MB, et al. Subpopulations of long-lived and short-lived T cells in advanced HIV-1 infection. J Clin Invest 2003; 112:956-66.
36. Sadiq ST, Taylor S, Kaye S, et al. The effects of antiretroviral therapy on HIV-1 RNA loads in seminal plasma in HIV-positive patients with and without urethritis. AIDS 2002; 16:219-25.
37. Finzi D, Hermankova M, Pierson T, et al. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 1997; 278:1295-300.
38. Schnittman SM, Psallidopoulos MC, Lane HC, et al. The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4. Science 1989; 245:305-8 (erratum: Science 1989; 245:preceding 694).
39. Perelson AS, Neumann AU, Markowitz M, Leonard JM, Ho DD. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 1996; 271:1582-6.
40. Cocchi F, DeVico AL, Garzino-Demo A, Arya SK, Gallo RC, Lusso P. Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science 1995; 270: 1811-5.
41. Kinter AL, Ostrowski M, Goletti D, et al. HIV replication in CD4+ T cells of HIV-infected individuals is regulated by a balance between the viral suppressive effects of endogenous beta-chemokines and the viral inductive effects of other endogenous cytokines. Proc Natl Acad Sci USA 1996; 93:14076-81.
42. Nkengasong JN, Kestens L, Ghys PD, et al. Human immunodeficiency virus type 1 (HIV-1) plasma virus load and markers of immune activation among HIV-infected female sex workers with sexually transmitted diseases in Abidjan, Cote d'Ivoire. J Infect Dis 2001; 183:1405-8.
43. Buchacz K, Patel P, Taylor M, et al. Syphilis increases HIV viral load and decreases CD4 cell counts in HIV-infected patients with new syphilis infections. AIDS 2004; 18:2075-9.
44. Kofoed K, Gerstoft J, Mathiesen LR, Benfield T. Syphilis and human immunodeficiency virus (HIV)-1 coinfection: influence on CD4 T-cell count, HIV-1 viral load, and treatment response. Sex Transm Dis 2006; 33:143-8.
45. Mole L, Ripich S, Margolis D, Holodniy M. The impact of active herpes simplex virus infection on human immunodeficiency virus load. J Infect Dis 1997; 176:766-70.
46. Gray RH, Li X, Wawer MJ, et al. Determinants of HIV-1 load in subjects with early and later HIV infections, in a general-population cohort of Rakai, Uganda. J Infect Dis 2004; 189:1209-15.
47. Schacker T, Zeh J, Hu H, Shaughnessy M, Corey L. Changes in plasma human immunodeficiency virus type 1 RNA associated with herpes simplex virus reactivation and suppression. J Infect Dis 2002; 186: 1718-25.
48. Kreiss JK, Coombs R, Plummer F, et al. Isolation of human immunodeficiency virus from genital ulcers in Nairobi prostitutes. J Infect Dis 1989; 160:380-4.